From owner-chemistry@ccl.net Tue Sep 11 11:45:01 2018 From: "Dan Robinhold Dan!=!CollaborativeDrug.com" To: CCL Subject: CCL: Webinar: A Discussion with Chris Lipinski and Barry Bunin Message-Id: <-53457-180911114327-25796-BvpggKL5htFVxq+xTpCobw .. server.ccl.net> X-Original-From: "Dan Robinhold" Date: Tue, 11 Sep 2018 11:43:24 -0400 Sent to CCL by: "Dan Robinhold" [Dan(_)CollaborativeDrug.com] Join us for a candid conversation with Chris Lipinski hosted by Barry Bunin. Register for the free webinar happening Thursday Sept. 13 at 9:00 US Pacific time, 12:00 Eastern and 16:00 GMT. Register here: https://hubs.ly/H0dpmGq0 Lipinskis Rule of 5 has become the established benchmark by which almost all drug discovery analyses are now compared. Lipinskis rule looks at hydrogen bond donors/acceptors, mass and partition coefficient to give a good guess of the likelihood a compound will be an orally effective drug. More info: https://www.collaborativedrug.com/a-discussion-with-chris- lipinski-and-barry-bunin/